This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Tue May 21, 2013 8:46 am


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Mon Oct 24, 2011 12:23 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1685
Image


New data from a late-stage trial showed that 78 percent of patients treated with Lemtrada remained relapse-free for two years, compared with 59 percent using Rebif, an older multiple sclerosis drug sold by Germany's Merck.

Lemtrada is a key experimental product at Sanofi's Genzyme unit. The fortunes of the drug are closely watched by holders of Genzyme Contingent Value Rights certificates issued to shareholders as part of the U.S. company's takeover deal.

CVRs represent an extra fee holders will receive if Lemtrada hits certain targets or when Genzyme meets other milestones.

The commercial potential of the drug, already sold under the brand name Campath as a leukemia treatment, was a key bone of contention between Sanofi and Genzyme during takeover talks.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1307

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Positive topline results for first phase 3 study of Lemtrada

squiffy2

6

1409

Mon Jul 18, 2011 7:43 am

patientx View the latest post

There are no new unread posts for this topic. In the Phase 3 Campath study!

queenie

0

1277

Wed Jun 03, 2009 4:48 pm

queenie View the latest post

There are no new unread posts for this topic. Allergies and Campath, update 6 months after Campath

[ Go to pageGo to page: 1, 2, 3 ]

Fighter

30

6308

Tue Nov 04, 2008 3:06 pm

Lyon View the latest post

There are no new unread posts for this topic. Approval sought for Lemtrada(TM) (alemtuzumab) for MS

squiffy2

0

727

Tue Jun 12, 2012 2:09 am

squiffy2 View the latest post

There are no new unread posts for this topic. Successful phase III results for Alemtuzumab (Lemtrada(TM*))

squiffy2

14

2609

Sun Aug 19, 2012 6:23 am

Gogo View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: